INS and diabetes mellitus: We also observed that diabetes reversal takes longer to achieve using human islets when compared to mouse islets that we have used in previous studies (18), likely due to the large size of human islets affecting engraftment and survival, the lower sensitivity of mouse host to human insulin, the smaller fraction of β cells in human islets as compared to mouse islets (34), and the longer human donor organ cold ischemia time (35).